BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28204898)

  • 1. Surgical treatment and outcome of TSH-producing pituitary adenomas.
    Rotermund R; Riedel N; Burkhardt T; Matschke J; Schmidt NO; Aberle J; Flitsch J
    Acta Neurochir (Wien); 2017 Jul; 159(7):1219-1226. PubMed ID: 28204898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas.
    Kim SH; Ku CR; Na M; Yoo J; Kim W; Jung IH; Kim KW; Moon JH; Kim D; Lee EJ; Kim SH; Kim EH
    J Neurosurg; 2020 Mar; 134(3):794-800. PubMed ID: 32168476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
    Gatto F; Grasso LF; Nazzari E; Cuny T; Anania P; Di Somma C; Colao A; Zona G; Weryha G; Pivonello R; Ferone D
    Pituitary; 2015 Oct; 18(5):583-91. PubMed ID: 25326851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and morphological characteristics, diagnostic criteria, and outcomes of surgical treatment of TSH-secreting pituitary adenomas.
    Astaf'eva LI; Kadashev BA; Shishkina LV; Kalinin PL; Fomichev DV; Kutin MA; Aref'eva IA; Dzeranova LK; Sidneva YG; Klochkova IS; Rotin DL
    Zh Vopr Neirokhir Im N N Burdenko; 2016; 80(6):24-35. PubMed ID: 28139570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center.
    Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
    Front Endocrinol (Lausanne); 2022; 13():1061029. PubMed ID: 36518240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of clinically silent thyrotropin pituitary adenomas: A single center series of 20 patients.
    Cyprich J; Donoho DA; Brunswick A; Hurth K; Carmichael JD; Weiss MH; Zada G
    J Clin Neurosci; 2020 Jan; 71():70-75. PubMed ID: 31668712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center.
    Herguido NG; Fuentes ED; Venegas-Moreno E; Maorad LB; Flores-Martinez A; Ruiz PR; Dueñas MC; Roldán F; Fajardo E; Ruiz-Valdepeñas EC; Kaen A; Martín Schrader I; Cano DA; Soto-Moreno A
    World Neurosurg; 2019 Oct; 130():e634-e639. PubMed ID: 31276853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
    Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
    J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the long-acting octreotide formulation in patients with thyroid-stimulating hormone-secreting pituitary adenomas after incomplete surgery and octreotide treatment failure.
    Zhang CF; Liang D; Zhong LY
    Chin Med J (Engl); 2012 Aug; 125(15):2758-63. PubMed ID: 22931988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed Complications After Transsphenoidal Surgery for Pituitary Adenomas.
    Alzhrani G; Sivakumar W; Park MS; Taussky P; Couldwell WT
    World Neurosurg; 2018 Jan; 109():233-241. PubMed ID: 28989047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
    Arafah BM
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and response cutoff of octreotide suppression test in thyrotrophin (TSH)-secreting pituitary adenomas.
    Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
    Clin Endocrinol (Oxf); 2023 Sep; 99(3):306-314. PubMed ID: 37144621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
    Kuhn JM; Arlot S; Lefebvre H; Caron P; Cortet-Rudelli C; Archambaud F; Chanson P; Tabarin A; Goth MI; Blumberg J; Catus F; Ispas S; Beck-Peccoz P
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution.
    D'Haens J; Van Rompaey K; Stadnik T; Haentjens P; Poppe K; Velkeniers B
    Surg Neurol; 2009 Oct; 72(4):336-40. PubMed ID: 19604551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation.
    Malchiodi E; Profka E; Ferrante E; Sala E; Verrua E; Campi I; Lania AG; Arosio M; Locatelli M; Mortini P; Losa M; Motti E; Beck-Peccoz P; Spada A; Mantovani G
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2069-76. PubMed ID: 24552222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures.
    Halvorsen H; Ramm-Pettersen J; Josefsen R; Rønning P; Reinlie S; Meling T; Berg-Johnsen J; Bollerslev J; Helseth E
    Acta Neurochir (Wien); 2014 Mar; 156(3):441-9. PubMed ID: 24343227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
    Bellut D; Hlavica M; Schmid C; Bernays RL
    Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perianesthetic Management of Patients With Thyroid-Stimulating Hormone-Secreting Pituitary Adenomas.
    Dyer MW; Gnagey A; Jones BT; Pula RD; Lanier WL; Atkinson JLD; Pasternak JJ
    J Neurosurg Anesthesiol; 2017 Jul; 29(3):341-346. PubMed ID: 27322091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.